Ask AI
ProCE Banner Events

Share

A Master Class in CP-CML: New Agents, Treatment Goals, and Clinical Challenges

Live satellite symposium with a panel of experts covering the latest clinical evidence on the management of patients with chronic phase CML, including recommendations on molecular assessments to guide therapeutic decision-making with tyrosine kinase inhibitors.

Friday Satellite Symposium preceding the ​67th ASH Annual Meeting and Exposition.

Physicians ABIM MOC: maximum of 2.00 Medical Knowledge MOC points

Physicians: maximum of 2.00 AMA PRA Category 1 Credits

This event has expired. No longer available for credits.

Who Should Attend

This educational activity is intended for hematologists, medical oncologists, and other healthcare professionals who care for patients with chronic-phase chronic myeloid leukemia

Time and location

Friday, December 05, 2025

11:00 AM - 1:30 PM Eastern Time (ET)

In-person

11:30 AM - 1:30 PM Eastern Time (ET)

Virtual

The Hyatt Regency Orlando
9801 International Dr.
Orlando, Florida 32819

Regency R

Agenda

Registration & Lunch: 11:00 AM - 11:30 AM ET

Symposium: 11:30 AM - 1:30 PM ET

 

Welcome, Introductions, and Baseline Assessments

  1. Evolving Standard of Care for Frontline Tyrosine Kinase Inhibitor (TKI) Therapy
    1. Interactive case challenges
    2. Available TKIS and patient education
  2. Optimal Risk Assessment, Monitoring of Response, and Testing for Intolerance or Resistance Mutations in Patients with Chronic Phase CML
    1. Risk stratification considerations
    2. Response milestones
    3. Monitoring response and TKI resistance testing
  3. Addressing Frontline Treatment Intolerance in Chronic Phase CML: Next Best Options
  4. CML Townhall Discussion of Audience Patient Cases and Related Abstracts to be Presented at ASH 2025

Closing Remarks and Q&A Session

Location

Venue Name

The Hyatt Regency Orlando

Address

The Hyatt Regency Orlando
9801 International Dr.
Orlando, Florida 32819

Room Name

Regency R

CME/CE Info

Goal Statement
This activity's goal is to improve the knowledge, competence, and confidence of learners to integrate new and emerging therapies into practice to improve clinical outcomes in patients with chronic-phase chronic myeloid leukemia 

Target Audience
This educational activity is intended for hematologists, medical oncologists, and other healthcare professionals who care for patients with chronic-phase chronic myeloid leukemia. 

Learning Objectives
Upon completion of this event, participants should be able to:

  • Differentiate important defining characteristics between TKIs and how these attributes influence efficacy and safety outcomes in chronic-phase CML
  • Implement individualized strategies for frontline treatment of chronic-phase CML based on clinical trial evidence, patient-specific factors, and BCR::ABL1 mutation status
  • Conduct optimal molecular and mutational monitoring during TKI treatment to guide the timing of therapy changes and subsequent therapy decisions in patients with chronic-phase CML
  • Select optimal subsequent therapy for patients with CP-CML who progress on or become intolerant to frontline TKI treatment

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC dba Decera Clinical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

CCO designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Board of Internal Medicine Maintenance of Certification 

A blue and black sign with white textDescription automatically generated

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

For ABIM MOC points, your information will be shared with the ABIM through Clinical Care Options, LLC dba Decera Clinical Education's Joint Accreditation Program and Activity Reporting System (JAPARS). Please allow 6-8 weeks for your MOC points to appear on your ABIM records.

By sharing your Diplomate Board ID # and DOB, you are giving Clinical Care Options, LLC dba Decera Clinical Education permission to use this information/data to report your participation to these Boards via the Joint Accreditation Program and Activity Reporting System (JA-PARS).

CME Passport

A logo for a companyDescription automatically generated

The CME credits that physicians earn from this activity will be submitted to ACCME's CME Passport, a free, centralized web application where you can create a personalized account to view, track, and generate transcripts of your reported CME credit. Visit www.cmepassport.org to create your account.

Disclosure of Conflicts of Interest
Decera Clinical Education requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to Decera Clinical Education policy. Decera Clinical Education is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company. 

Acknowledgement

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education.

CCO 2022

Supporter

Supported by an educational grant from Novartis Pharmaceuticals Corporation.

Novartis Pharmaceuticals Corporation

Contact Information

For customer support please click here.

Mailing Address:

 

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 304
Reston, VA 20191

Additional Information

There are no fees required to participate in this activity.

Americans With Disabilities Act 
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact customer support prior to the live event.